User profiles for Robert Challen

Robert Challen

University of Bristol
Verified email at bristol.ac.uk
Cited by 1888

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

R Challen, E Brooks-Pollock, JM Read, L Dyson… - bmj, 2021 - bmj.com
Objective To establish whether there is any change in mortality from infection with a new
variant of SARS-CoV-2, designated a variant of concern (VOC-202012/1) in December 2020, …

Artificial intelligence, bias and clinical safety

R Challen, J Denny, M Pitt, L Gompels… - BMJ quality & …, 2019 - qualitysafety.bmj.com
In medicine, artificial intelligence (AI) research is becoming increasingly focused on applying
machine learning (ML) techniques to complex problems, and so allowing computers to …

Increased hazard of mortality in cases compatible with SARS-CoV-2 variant of concern 202012/1-a matched cohort study

R Challen, E Brooks-Pollock, JM Read, L Dyson… - MedRxiv, 2021 - medrxiv.org
Objectives To establish whether there is any change in mortality associated with infection of
a new variant of SARS-CoV-2, designated a Variant of Concern in December 2020 (VOC-…

[HTML][HTML] Severity of Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United …

C Hyams, R Challen, R Marlow, J Nguyen… - The Lancet Regional …, 2023 - thelancet.com
Background There is an urgent public health need to evaluate disease severity in adults
hospitalised with Delta and Omicron SARS-CoV-2 variant infections. However, limited data exist …

Early epidemiological signatures of novel SARS-CoV-2 variants: establishment of B. 1.617. 2 in England

R Challen, L Dyson, CE Overton, LM Guzman-Rincon… - MedRxiv, 2021 - medrxiv.org
The rapid emergence of SARS-CoV-2 mutants with new phenotypic properties is a critical
challenge to the control of the ongoing pandemic. B.1.1.7 was monitored in the UK through …

Commentary on the use of the reproduction number R during the COVID-19 pandemic

…, F Ball, E Brooks-Pollock, R Challen… - … Methods in Medical …, 2022 - journals.sagepub.com
Since the beginning of the COVID-19 pandemic, the reproduction number [Formula: see text]
has become a popular epidemiological metric used to communicate the state of the …

[HTML][HTML] Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006‒2022

C Hyams, R Challen, D Hettle… - Emerging Infectious …, 2023 - ncbi.nlm.nih.gov
Ongoing surveillance after pneumococcal conjugate vaccination (PCV) deployment is
essential to inform policy decisions and monitor serotype replacement. We report serotype and …

[HTML][HTML] Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study

C Hyams, R Challen, E Begier, J Southern… - The Lancet Regional …, 2022 - thelancet.com
Background The emergence of COVID-19 and public health measures implemented to
reduce SARS-CoV-2 infections have both affected acute lower respiratory tract disease (aLRTD) …

[HTML][HTML] A flexible method for optimising sharing of healthcare resources and demand in the context of the COVID-19 pandemic

L Lacasa, R Challen, E Brooks-Pollock, L Danon - Plos one, 2020 - journals.plos.org
As the number of cases of COVID-19 continues to grow, local health services are at risk of
being overwhelmed with patients requiring intensive care. We develop and implement an …

[HTML][HTML] Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B. 1.617. 2) and …

A Chatzilena, C Hyams, R Challen… - The Lancet Regional …, 2023 - thelancet.com
Background Whilst other studies have reported the effectiveness of mRNA vaccination against
hospitalisation, including emergency department or intensive care admission, few have …